I-Cure Laboratories Private Limited
About I-Cure Laboratories Private Limited
Data last updated:
I-Cure Laboratories Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 21 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24110HR2020PTC084862.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Pandey (Whole-Time Director) and Neelam Pandey (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 18/2 Hari Nagar Behind B D Floor Mill, Ambala, Haryana, India – 133001.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.46 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹28,065 (net margin 1%) and EBITDA of ₹1.03 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
I-Cure Laboratories Private Limited's registered office is in Ambala, Haryana.
- Registered AddressH. No. 18/2 Hari Nagar Behind B D Floor Mill, Ambala, Haryana, India – 133001
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of I-Cure Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of I-Cure Laboratories Private Limited, buy the company report.
Financials of I-Cure Laboratories Private Limited
FY 2025 filings availableI-Cure Laboratories Private Limited reported revenue of ₹27.46 Lakh (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 2% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,065 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of I-Cure Laboratories Private Limited, buy the company report.
Board of directors of I-Cure Laboratories Private Limited
I-Cure Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Pandey | Whole-Time Director | 18 Feb 2021 | 5 Years 8 Months | Current |
| Neelam Pandey | Whole-Time Director | 18 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
I-Cure Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Disha Resources Limited | ₹27.47 Lakh (FY 2025) | -94.0% | Ahmedabad, Gujarat, India | |||
| Capillon Pharma Private Limited | ₹27.47 Lakh (FY 2024) | -14.0% | Baddi, Himachal Pradesh, India | |||
| Skin Habits Private Limited | ₹27.47 Lakh (FY 2024) | 234.0% | Chandigarh, India | |||
| Cranberry Enterprises Private Limited | ₹27.47 Lakh (FY 2018) | -69.0% | Kolkata, West Bengal, India | |||
| Dan Buildcon Private Limited | ₹27.47 Lakh (FY 2022) | -36.0% | Delhi, India | |||
| I-Cure Laboratories Private Limitedthis company | ₹27.46 Lakh (FY 2024) | ₹28,065 | 1% | 2.0% | Ambala, Haryana, India | |
| Mohitvimal Jewellers Private Limited | ₹27.46 Lakh (FY 2024) | 187.0% | Jaunpur, Uttar Pradesh, India | |||
| JPS Trexim Pvt Ltd | ₹27.46 Lakh (FY 2025) | -53.0% | Kolkata, West Bengal, India | |||
| Ghanshyam Trade-Link Private Limited | ₹27.46 Lakh (FY 2024) | 7.0% | Nagpur, Maharashtra, India | |||
| Tidke Farmer Producer Company Limited | ₹27.46 Lakh (FY 2025) | 31.0% | Nanded, Maharashtra, India | |||
| Sajama Integrated Marketing Solutions Private Limited | ₹27.46 Lakh (FY 2015) | -45.0% | New Delhi, Delhi, India |
To see the full peer comparison of I-Cure Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving I-Cure Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for I-Cure Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for I-Cure Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
I-Cure Laboratories Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Manoj Pandey ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
I-Cure Laboratories is an active private limited company based in Ambala, Haryana, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 21 January 2020 (6+ years old) and is registered under CIN U24110HR2020PTC084862.
I-Cure Laboratories has 2 current directors:
- Manoj Pandey - Whole-Time Director
- Neelam Pandey - Whole-Time Director
The latest financial statements of I-Cure Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of I-Cure Laboratories is U24110HR2020PTC084862. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I-Cure Laboratories was incorporated on 21 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of I-Cure Laboratories by revenue are Disha Resources Limited, Capillon Pharma Private Limited, Skin Habits Private Limited, Cranberry Enterprises Private Limited, Dan Buildcon Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Manoj Pandey ceased to be Additional Director on 30 Sep 2022. Mukesh Kumar Dvivedi ceased to be Whole-Time Director on 30 Sep 2022. Neelam Pandey ceased to be Additional Director on 30 Sep 2022. I-Cure Laboratories has 6 board changes on record in total.
The registered office of I-Cure Laboratories is at H. No. 182 Hari Nagar Behind B D Floor Mill, Ambala, Haryana, India – 133001.
I-Cure Laboratories operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
The compliance status of I-Cure Laboratories is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.
I-Cure Laboratories can be reached at its registered office: H. No. 182 Hari Nagar Behind B D Floor Mill, Ambala, Haryana, India – 133001.